Physician profile
Sandeep Joshi
NPI 1124266119
$1,275.35
in general payments reported to CMS, 2019-2025
12 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $148 · 2021: $12.66 · 2022: $208 · 2023: $39.23 · 2024: $251 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $560.35 | 2019-2020 | |
| Atricure, INC. | $162.33 | 2022 | |
| Penumbra, INC. | $133.79 | 2024 | Indigo System |
| Novartis Pharmaceuticals Corporation | $127.57 | 2024-2025 | |
| Amgen INC. | $124.59 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $36.13 | 2019-2023 | Eliquis |
| Astrazeneca Pharmaceuticals Lp | $29.70 | 2019-2024 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $27.05 | 2019 | |
| Cagent Vascular INC | $24.38 | 2022 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Cvrx, INC. | $15.10 | 2023 | Barostim Neo System |
| Chiesi USA, INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.